Literature DB >> 17321577

Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice.

David S Southam1, Russ Ellis, Jennifer Wattie, Mark D Inman.   

Abstract

BACKGROUND: Pathologic changes, including inflammation and remodeling, occur in the asthmatic airway. However, their relative contribution to the components of airway hyperresponsiveness (AHR) remains unclear.
OBJECTIVE: Attempting to delineate AHR into discrete immune-mediated and structural remodeling components, we performed a detailed time course of the development, progression, and persistence of maximal respiratory system resistance, airway reactivity, and airway sensitivity.
METHODS: Mice exposed to increasing durations of persistent allergen were assessed for airway function, morphometry, and inflammation.
RESULTS: Allergen exposure resulted in increases for all indices of AHR that persisted for at least 4 weeks after chronic allergen exposure (P < .01 for all values). Early increases in AHR were associated with increases in immune-mediated events, including airway eosinophils (P < .01), whereas sustained AHR was associated with structural remodeling events. Increased maximal respiratory system resistance, evident by 6 weeks postallergen and persisting for at least 4 weeks after 8 weeks of chronic exposure, was associated with an increase in collagen deposition (P < .01). Increased airway reactivity and sensitivity, each evident by 1 week after allergen and persisting for at least 4 weeks after 8 weeks of chronic exposure, were associated with an increase in airway smooth muscle area (P < .01).
CONCLUSION: Our novel observation of distinct temporal relationships in the development, progression, and persistence of the individual indices of AHR supports our hypothesis that multiple underlying factors contribute to airway dysfunction. CLINICAL IMPLICATIONS: These findings illustrate the importance of clearly addressing specific components of airway dysfunction to provide greater insight into specific pathophysiologic mechanisms in airway disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321577     DOI: 10.1016/j.jaci.2006.12.623

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  24 in total

1.  The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling.

Authors:  Taylor A Doherty; Pejman Soroosh; Naseem Khorram; Satoshi Fukuyama; Peter Rosenthal; Jae Youn Cho; Paula S Norris; Heonsik Choi; Stefanie Scheu; Klaus Pfeffer; Bruce L Zuraw; Carl F Ware; David H Broide; Michael Croft
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

Review 2.  Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.

Authors:  Raymond B Penn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

Review 3.  Animal models of asthma.

Authors:  Jason H T Bates; Mercedes Rincon; Charles G Irvin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-26       Impact factor: 5.464

4.  GSTM1, GSTP1, and NQO1 polymorphisms and susceptibility to atopy and airway hyperresponsiveness among South African schoolchildren.

Authors:  Poovendhree Reddy; Rajen N Naidoo; Thomas G Robins; Graciela Mentz; Stephanie J London; Huiling Li; Richard Naidoo
Journal:  Lung       Date:  2010-06-05       Impact factor: 2.584

Review 5.  Transforming Growth Factor β1 Function in Airway Remodeling and Hyperresponsiveness. The Missing Link?

Authors:  Christie A Ojiaku; Edwin J Yoo; Reynold A Panettieri
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

6.  Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma.

Authors:  James D Nolin; H Luke Ogden; Ying Lai; William A Altemeier; Charles W Frevert; James G Bollinger; Gajendra S Naika; Anthony Kicic; Stephen M Stick; Gerard Lambeau; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

7.  Concurrent dual allergen exposure and its effects on airway hyperresponsiveness, inflammation and remodeling in mice.

Authors:  Franco A DiGiovanni; Russ Ellis; Jennifer Wattie; Jeremy A Hirota; David S Southam; Mark D Inman
Journal:  Dis Model Mech       Date:  2009-04-06       Impact factor: 5.758

8.  Recurring BALB/c mouse lung inflammatory responses to episodic allergen exposure.

Authors:  S J Wilson; M J Harmer; R L Lee; H M Rigden; N M Doyon-Reale; K M Forman; X Gao; M W Lieh-Lai; D J P Bassett
Journal:  J Toxicol Environ Health A       Date:  2013

9.  Reduced levels of maternal progesterone during pregnancy increase the risk for allergic airway diseases in females only.

Authors:  Isabel R V Hartwig; Christian A Bruenahl; Katherina Ramisch; Thomas Keil; Mark Inman; Petra C Arck; Maike Pincus
Journal:  J Mol Med (Berl)       Date:  2014-06-03       Impact factor: 4.599

10.  Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model.

Authors:  A C Toledo; C P P Sakoda; A Perini; N M Pinheiro; R M Magalhães; S Grecco; I F L C Tibério; N O Câmara; M A Martins; J H G Lago; C M Prado
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.